Pfizer on Tuesday requested the Food and Drug Administration allow all Americans over 18 to be eligible for booster shots, submitting data from a 10,000-person trial that found its third shots to be safe and effective for adults of all ages. MORE: CDC director overrules panel on Pfizer boosters for front-line workersPfizer’s submission on Tuesday brings more data to the table. The FDA and CDC have both left the door open to widening booster recommendations out to everyone as more data comes out, and as immunity wanes. "But the advantage of a third dose is that you're less likely to have an asymptotic or mildly symptomatic infection. Pfizer asks FDA to amend booster authorization to include all adults originally appeared on abcnews.go.com

Source: ABC News November 10, 2021 02:54 UTC